More Post from the Author
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
InventHelp Inventor Develops Anti-Bully Athletic Shoe (TPL-461)
PITTSBURGH, March 20, 2025 /PRNewswire/ -- "I wrote a children's book and wanted to create a companion athletic shoe that could be worn to help inspire discussions about school bullying," said an inventor, from Jacksonville, Fla., "so I invented the OUR KIDS MATTER. My unique footwear design could help stop school bullying."
The invention provides a new athletic shoe designed for children. In doing so, it may inspire wearers or parents to discuss bullying. As a result, it could help reduce instances of school bullying and the associated violence. The invention features a unique design that is easy to wear so it is ideal for children and teens. Additionally, it is producible in design variations.
The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 23-TPL-461, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
SOURCE InventHelp

More Post from the Author
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
